de Urioste George 4

What Happened

• Director George de Urioste was granted a derivative award (Special Option) covering 51,724 shares of HeartBeam common stock on Feb 9, 2026. The Form 4 lists the acquisition price as $0.00 (grant of options), so no cash purchase was made.

Key Details

• Transaction date: 2026-02-09 (reported on Form 4 filed 2026-03-23). Filing appears late relative to the 2-business-day Form 4 deadline.
• Transaction code: A (award/grant); derivative transaction (options), not a stock sale or open-market purchase.
• Shares granted: 51,724 option shares; reported acquisition price: $0.00.
• Vesting (per footnote): half of the Shares vest on March 31, 2026 (3-month anniversary of vesting commencement date Jan 1, 2026); remaining Shares vest on June 30, 2026 (6-month anniversary).
• Source: Options issued under the Company’s 2022 Equity Incentive Plan.
• Shares owned after transaction: not specified in the provided filing summary.

Context

• This was a compensation grant of options, not a purchase or sale. Grants are common for directors and reflect equity compensation rather than a direct market signal. The options do not appear to have been exercised or sold; vesting is scheduled in two installments. The late filing means the disclosure to the public was delayed beyond the normal Form 4 deadline.